Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like Drug Company Pays Physicians Who Subscribe High-Priced Gel, Study Finds July 4, 2018 Foreign Governments ‘Free-Riding’ on U.S. Drug Research, White House Says February 20, 2020 Sanofi, Regeneron Push Supreme Court to Deny Amgen’s Cholesterol Patent Monopoly February 6, 2023